Odysight.ai Reports Financial Results for The Nine Months Ended September 30, 2025 and Provides Business Update
Odysight.ai (NASDAQ: ODYS) reported results for the nine months ended September 30, 2025. Revenues were approximately $2.6M, cash balance was approximately $29.8M, and backlog was approximately $14.2M. Gross profit was $0.7M with a gross margin of ~27%. Operating expenses increased to $14.4M, driving a net loss of $12.8M. Management highlighted a strategic pivot from medical to aerospace, transportation and industrial sectors, monetization of backlog beginning in 2025, European flight tests on AW139, deliveries for Heron TP UAV and a commercial PO for 200 industrial units. The company uplisted to Nasdaq in February 2025 and completed a U.S. offering with gross proceeds of approximately $23.7M.
Odysight.ai (NASDAQ: ODYS) ha riportato i risultati per i nove mesi chiusi al 30 settembre 2025. I ricavi erano circa $2,6 milioni, la posizione di cassa era circa $29,8 milioni, e il backlog era circa $14,2 milioni. Il profitto lordo era di $0,7 milioni con un margine lordo di circa 27%. Le spese operative sono aumentate a $14,4 milioni, provocando una perdita netta di $12,8 milioni. La direzione ha evidenziato una svolta strategica dai settori medical agli aerospaziale, dei trasporti e industriali, la monetizzazione del backlog a partire dal 2025, test di volo europei sull'AW139, consegne per l' e un ordine commerciale per 200 unità industriali. L'azienda si è quotata al Nasdaq a febbraio 2025 e ha completato un'offerta negli Stati Uniti con proventi lordi di circa $23,7 milioni.
Odysight.ai (NASDAQ: ODYS) informó los resultados de los nueve meses terminados al 30 de septiembre de 2025. Los ingresos fueron aproximadamente $2,6 millones, el saldo de caja fue aproximadamente $29,8 millones, y el backlog fue aproximadamente $14,2 millones. La ganancia bruta fue de $0,7 millones con un margen bruto de ~27%. Los gastos operativos aumentaron a $14,4 millones, provocando una pérdida neta de $12,8 millones. La dirección destacó un cambio estratégico de los sectores médicos hacia aeroespacial, transporte e industrial, la monetización del backlog a partir de 2025, pruebas de vuelo europeas en AW139, entregas para UAV Heron TP y un PO comercial para 200 unidades industriales. La empresa se listó en Nasdaq en febrero de 2025 y completó una oferta en EE. UU. con ingresos brutos de aproximadamente $23,7 millones.
Odysight.ai (NASDAQ: ODYS)는 2025년 9월 30일 종료된 9개월 실적을 발표했습니다. 매출은 약 $2.6M, 현금 잔고는 약 $29.8M, 백로그는 약 $14.2M였습니다. 총이익은 $0.7M이고 총이익률은 약 27%였습니다. 영업비용은 14.4M으로 증가했고 순손실은 $12.8M를 기록했습니다. 경영진은 의료에서 항공우주, 운송, 산업 부문으로의 전략적 전환, 2025년부터의 백로그 수익화, AWS139의 유럽 비행 테스트, Heron TP UAV 납품, 200대의 산업 유닛에 대한 상업 주문을 강조했습니다. 회사는 2025년 2월에 나스닥 상장했고 미국 공모를 통해 총 수익 2370만 달러의 자금을 조달했습니다.
Odysight.ai (NASDAQ : ODYS) a publié les résultats des neuf mois se terminant le 30 septembre 2025. Les revenus étaient d'environ $2,6 millions, le solde de trésorerie était d'environ $29,8 millions, et le carnet de commandes était d'environ $14,2 millions. Le bénéfice brut était de $0,7 million avec une marge brute d'environ 27%. Les dépenses d'exploitation ont augmenté à $14,4 millions, ce qui a entraîné une perte nette de $12,8 millions. La direction a souligné une pivot stratégique des secteurs médicaux vers l'aérospatial, les transports et l'industrie, la monétisation du carnet de commandes à partir de 2025, des essais de vol européens sur l'AW139, des livraisons pour le UAV Heron TP et une commande commerciale pour 200 unités industrielles. L'entreprise a été cotée au Nasdaq en février 2025 et a mené une offre aux États-Unis avec des produits bruts d'environ $23,7 millions.
Odysight.ai (NASDAQ: ODYS) hat Ergebnisse für die neun Monate zum 30. September 2025 gemeldet. Umsätze lagen bei ca. $2,6 Mio., Barbestand bei ca. $29,8 Mio., und Rückstand bei ca. $14,2 Mio.. Der Bruttogewinn betrug $0,7 Mio. mit einer Bruttomarge von ca. 27%. Die operativen Aufwendungen stiegen auf $14,4 Mio., was zu einem Nettoverlust von $12,8 Mio. führte. Das Management hob eine strategische Neuausrichtung von medizinischen zu Luft- und Raumfahrt-, Transport- und Industriesektoren hervor, die Monetarisierung des Backlogs ab 2025, europäische Flugtests mit dem AW139, Lieferungen für den Heron TP UAV und eine kommerzieller Auftrag für 200 Industrieeinheiten. Das Unternehmen wurde im Februar 2025 an der Nasdaq aufgehübt und hat eine US-IPO mit Bruttoerlösen von ca. $23,7 Mio. abgeschlossen.
Odysight.ai (NASDAQ: ODYS) أبلغت عن النتائج للثلاثة أرباع المنتهية في 30 سبتمبر 2025. كانت الإيرادات نحو $2.6M، رصيد النقد نحو $29.8M، وال backlog نحو $14.2M. كان الربح الإجمالي نحو $0.7M مع هامش إجمالي نحو 27%. ارتفعت المصروفات التشغيلية إلى $14.4M، مما أدى إلى خسارة صافية قدرها $12.8M. أشارت الإدارة إلى انعطاف استراتيجي من الطبي إلى الفضاء الجوي والاتصالات والنِّـسِج الصناعية، واستثمار من backlog ابتداءً من 2025، واختبارات طيران أوروبية على AW139, وتسليمات لـ Heron TP UAV، وأمر شراء تجاري لـ 200 وحدة صناعية. قامت الشركة بالإدراج في ناسداك في فبراير 2025 وأتمت عرضًا أمريكيًا بتدفقات نقدية إجمالية تقارب $23.7M.
- Cash balance of $29.8M as of September 30, 2025
- Backlog of $14.2M providing revenue visibility into 2026
- Gross margin of ~27% for the nine months
- Completed uplisting and $23.7M gross proceeds in Feb 2025
- Net loss of $12.8M for the nine months ended Sep 30, 2025
- Operating expenses rose to $14.4M, up from $9.4M prior year
- Revenues slightly declined to $2.6M from $2.7M year ago
Insights
Solid liquidity and a material backlog support near‑term revenue visibility, while rising operating spend keeps results loss‑making.
Business mechanism: Odysight.ai recorded approximately
Dependencies and risks: Revenues remain near prior‑year levels while operating expenses rose to
Concrete items to watch: monitor conversion of the
OMER, Israel, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Odysight.ai Inc. (NASDAQ: ODYS), a leading provider of visual based predictive maintenance (PdM) and condition-based monitoring (CBM) solutions, announces its financial results for the nine months ended September 30, 2025, and provides a business update.
Key highlights for the nine months ended September 30, 2025
| ● | Revenues for the first nine months of 2025 were approximately Backlog of approximately | |
| ● | Strengthened our global presence with important commercial achievements: | |
| - | Completed the transition from focusing on the medical sector to the aerospace, transportation and industrial sectors, with commercial aerospace revenues booked in 2025. | |
| - | Successful completion of a European flight of our system on an AW139 Leonardo helicopter tested by the Italian Air Force. This milestone represents Odysight.ai’s first operational footprint in Europe, a significant step forward as the Company expands into the world’s second largest helicopter market. | |
| - | Completed the delivery of a vision-based monitoring system for the Heron TP UAV, a remotely piloted aircraft system. The system, developed by Odysight.ai for Israel’s Ministry of Defense (MOD), provides advanced remote monitoring capabilities using specialized algorithms and a miniature sensor-based optical system. | |
| - | Signed a strategic partnership with a multinational technology group to integrate Odysights’s predictive health monitoring (PHM) system on several platforms. The proof-of-concept deployment is focused on selected heavy vehicles across the fields of defense, mining, agriculture and heavy autonomous vehicle sectors. | |
| - | Received a PO for the first commercial batch of 200 Industrial Predictive Monitoring Systems from a leading European provider of industrial sensing and monitoring solutions. | |
| - | Deployed Odysight’s PHM system to prevent derailments and enhance railway safety in partnership with Israel Railways. Ongoing discussions to further expand deployment. |
Yehu Ofer, Chief Executive Officer of Odysight.ai: “The first nine months of 2025 mark a transformative phase for Odysight.ai. We have built the foundation for sustained growth. The monetization of our backlog has begun, reflecting increasing market adoption of our visual sensing and AI analytics dual use technologies across both unmanned and manned platforms. Our strategic pivot from the medical device market to aerospace, transportation, and industrial sectors is now clearly starting to deliver results. From our TruVision® European flight on the AW139 with the Italian Air Force—our first operational footprint in Europe—to our deployments on UAVs, SH-60 Seahawk aircraft and heavy industrial platforms, Odysight.ai is executing on a global scale. The recent delivery of our system for the Heron TP UAV and our predictive health monitoring deployments with Israel Railways and a leading European industrial partner underscore our ability to translate cutting-edge technology into real-world impact. We remain focused on expanding our backlog as we continue building Odysight.ai into a global leader in intelligent vision-based monitoring and predictive analytics.”
Einav Brenner, Chief Financial Officer of Odysight.ai: “The financial results for the first nine months of 2025 reflect a disciplined execution of our growth strategy. With revenues of approximately
1 Including cash, cash equivalents and restricted cash.
2 Backlog is measured and defined differently by companies within our industry. We refer to “backlog” as our booked orders based on purchase orders or hard commitments but not yet recognized as revenue. Backlog is not a comprehensive indicator of future revenue and is not a measure of profitability. Orders included in backlog may be cancelled or rescheduled by customers. A variety of conditions, both specific to the individual customer and generally affecting the customer’s industry, may cause customers to cancel, reduce or delay orders that were previously made or anticipated. Projects may remain in backlog for extended periods of time.
Financial highlights for the nine months ended September 30, 2025
Revenues were approximately
Revenues for the nine months ended September 30, 2025 were primarily comprised of
Backlog2 was approximately
Cost of Revenues was
Gross Profit was
Operating expenses were
Net loss was
Cash Balance1 as of September 30, 2025 was
About Odysight.ai
Odysight.ai, incorporated in Nevada U.S., with European and Israeli subsidiaries, is pioneering the Predictive Maintenance (PdM) and Condition Based Monitoring (CBM) markets with its visualization and AI platform. Providing video sensor-based solutions for critical systems in the aviation, transportation, and energy industries, Odysight.ai leverages proven visual technologies and products from the medical industry. Odysight.ai’s unique video-based sensors, embedded software, and AI algorithms are being deployed in hard-to-reach locations and harsh environments across a variety of PdM and CBM use cases. Odysight.ai’s platform allows maintenance and operations teams visibility into areas which are inaccessible under normal operation, or where the operating ambience is not suitable for continuous real-time monitoring.
We routinely post information that may be important to investors in the Investors section of our website. For more information, please visit: http://www.odysight.ai or follow us on Twitter, LinkedIn and YouTube.
Backlog
We present our results of operations in a way that we believe will be the most meaningful and useful to investors, analysts, rating agencies and others who use our financial information to evaluate our performance. Backlog is presented for supplemental informational purposes only, and is not intended to be a substitute for any GAAP financial measures, including revenue or net income (loss), and, as calculated, may not be comparable to companies in other industries or within the same industry with similarly titled measures of performance. In addition, backlog should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. Therefore, backlog should be considered in addition to, not as a substitute for, or in isolation from, measures prepared in accordance with GAAP.
Forward-Looking Statements
Information set forth in this news release contains forward-looking statements within the meaning of safe harbor provisions of the Private Securities Litigation Reform Act of 1995 relating to future events or our future performance. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, but not limited to, expectations regarding monetization of backlog, the potential for the expansion of the backlog and statements regarding long-term growth prospects. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other comparable terminology. Those statements are based on information we have when those statements are made or our management’s current expectation and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward- looking statements. Factors that may affect our results, performance, circumstances or achievements include, but are not limited to the following: (i) market acceptance of our existing and new products, including those that utilize our micro Odysight.ai technology or offer Predictive Maintenance and Condition Based Monitoring applications, (ii) lengthy product delays in key markets, (iii) an inability to secure regulatory approvals for the sale of our products, (iv) intense competition in the medical device and related industries from much larger, multinational companies, (v) product liability claims, product malfunctions and the functionality of Odysight.ai’s solutions under all environmental conditions, (vi) our limited manufacturing capabilities and reliance on third-parties for assistance, (vii) an inability to establish sales, marketing and distribution capabilities to commercialize our products, (viii) an inability to attract and retain qualified personnel, (ix) our efforts obtain and maintain intellectual property protection covering our products, which may not be successful, (x) our reliance on a single customer that accounts for a substantial portion of our revenues, (xi) our reliance on single suppliers for certain product components, including for miniature video sensors which are suitable for our Complementary Metal Oxide Semiconductor technology products, (xii) the fact that we will need to raise additional capital to meet our business requirements in the future and that such capital raising may be costly, dilutive or difficult to obtain, (xiii) the impact of computer system failures, cyberattacks or deficiencies in our cybersecurity, (xiv) the fact that we conduct business in multiple foreign jurisdictions, exposing us to foreign currency exchange rate fluctuations, logistical, global supply chain and communications challenges, burdens and costs of compliance with foreign laws and political and economic instability in each jurisdiction, including the adoption or expansion of economic sanctions, tariffs or trade restrictions and (xv) political, economic and military instability in Israel, including the impact of Israel’s war against Hamas, Hezbollah and Iran. These and other important factors discussed in Odysight.ai’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 26, 2025, and our other reports filed with the SEC, could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Except as required under applicable securities legislation, Odysight.ai undertakes no obligation to publicly update or revise forward-looking information.
Company Contact:
Einav Brenner, CFO
info@odysight.ai
Investor Relations Contact:
Miri Segal
MS-IR LLC
msegal@ms-ir.com
Tel: +1-917-607-8654
ODYSIGHT.AI INC.
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
| Nine months ended September 30, | Three months ended September 30, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Unaudited | ||||||||||||||||
| USD in thousands | ||||||||||||||||
| REVENUES | 2,576 | 2,660 | 149 | 1,292 | ||||||||||||
| COST OF REVENUES | 1,882 | 1,964 | 126 | 887 | ||||||||||||
| GROSS PROFIT | 694 | 696 | 23 | 405 | ||||||||||||
| RESEARCH AND DEVELOPMENT EXPENSES | 7,322 | 4,705 | 2,479 | 1,730 | ||||||||||||
| SALES AND MARKETING EXPENSES | 1,604 | 806 | 580 | 347 | ||||||||||||
| GENERAL AND ADMINISTRATIVE EXPENSES | 5,473 | 3,929 | 1,671 | 1,344 | ||||||||||||
| OPERATING LOSS | (13,705 | ) | (8,744 | ) | (4,707 | ) | (3,016 | ) | ||||||||
| FINANCING INCOME, NET | 949 | 533 | 291 | 149 | ||||||||||||
| NET LOSS | (12,756 | ) | (8,211 | ) | (4,416 | ) | (2,867 | ) | ||||||||
ODYSIGHT.AI INC.
INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS
| September 30, 2025 | December 31, 2024 | |||||||
| Unaudited | Audited | |||||||
| USD in thousands | ||||||||
| Assets | ||||||||
| CURRENT ASSETS: | ||||||||
| Cash and cash equivalents | 29,482 | 18,164 | ||||||
| Restricted cash | 331 | - | ||||||
| Restricted deposit | - | 322 | ||||||
| Accounts receivable | 354 | 1,510 | ||||||
| Inventory | - | 203 | ||||||
| Other current assets | 1,173 | 588 | ||||||
| Total current assets | 31,340 | 20,787 | ||||||
| NON-CURRENT ASSETS: | ||||||||
| Contract fulfillment assets | - | 1,017 | ||||||
| Property and equipment, net | 360 | 407 | ||||||
| Operating lease right-of-use assets | 833 | 1,113 | ||||||
| Severance pay asset | 286 | 259 | ||||||
| Other non-current assets | 96 | 96 | ||||||
| Total non-current assets | 1,575 | 2,892 | ||||||
| TOTAL ASSETS | 32,915 | 23,679 | ||||||
| Liabilities and shareholders’ equity | ||||||||
| CURRENT LIABILITIES: | ||||||||
| Accounts payable | 357 | 442 | ||||||
| Contract liabilities - short term | 240 | 702 | ||||||
| Operating lease liabilities - short term | 535 | 539 | ||||||
| Accrued compensation expenses | 1,276 | 1,124 | ||||||
| Related parties | 230 | 120 | ||||||
| Other current liabilities | 568 | 368 | ||||||
| Total current liabilities | 3,206 | 3,295 | ||||||
| NON-CURRENT LIABILITIES: | ||||||||
| Contract liabilities - long term | - | 1,373 | ||||||
| Operating lease liabilities - long term | 309 | 508 | ||||||
| Liability for severance pay | 286 | 259 | ||||||
| Total non-current liabilities | 595 | 2,140 | ||||||
| TOTAL LIABILITIES | 3,801 | 5,435 | ||||||
| SHAREHOLDERS’ EQUITY: | ||||||||
| Common stock, | 17 | 13 | ||||||
| Additional paid-in capital | 87,827 | 64,205 | ||||||
| Accumulated deficit | (58,730 | ) | (45,974 | |||||
| TOTAL SHAREHOLDERS’ EQUITY | 29,114 | 18,244 | ||||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | 32,915 | 23,679 | ||||||
FAQ
What were Odysight.ai (ODYS) revenues for the nine months ended Sep 30, 2025?
How much cash did Odysight.ai (ODYS) hold at Sep 30, 2025 and why does it matter?
What is Odysight.ai's (ODYS) backlog size and expected timing of revenue recognition?
Why did Odysight.ai (ODYS) report a larger loss in 2025 versus 2024?
What commercial milestones did Odysight.ai (ODYS) announce in 2025 that affect growth?
Did Odysight.ai (ODYS) raise capital in 2025 and how much?
